Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CD11781/I, CD10394/101A, and CD11406/B in a psoriasis transplant model
NL-OMON42829Active, not recruiting
- Sponsor
- Derphartox
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of clobetasol, curcumin and pimecrolimus in psoriasis (3 arms), sponsored by Derphartox. Started Oct 2016; status: active, not recruiting.
02
Drugs
clobetasolcurcuminpimecrolimus
03
Conditions
psoriasis
Beyond the preview
Go deeper on NL-OMON42829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42829.